CBT - Cabot Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
Boston,
United States
Type: Equity
CBT price evolution
CBT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $197 | $206 | $244 | |
| Short term investments | ||||
| Net receivables | $733 | $732 | $744 | $726 |
| Inventory | $552 | $553 | $551 | $617 |
| Total current assets | $1605 | $1591 | $1605 | $1692 |
| Long term investments | $24 | $22 | $21 | |
| Property, plant & equipment | $1534 | $1430 | $1427 | $1444 |
| Goodwill & intangible assets | $187 | $196 | $199 | |
| Total noncurrent assets | $1989 | $1991 | $2003 | |
| Total investments | $24 | $22 | $21 | |
| Total assets | $3736 | $3580 | $3596 | $3695 |
| Current liabilities | ||||
| Accounts payable | $676 | $626 | $587 | $585 |
| Deferred revenue | ||||
| Short long term debt | $57 | $96 | $214 | |
| Total current liabilities | $772 | $717 | $718 | $830 |
| Long term debt | $1087 | $1083 | $1088 | $1098 |
| Total noncurrent liabilities | $1367 | $1371 | $1390 | |
| Total debt | $1140 | $1184 | $1312 | |
| Total liabilities | $2311 | $2084 | $2089 | $2220 |
| Shareholders' equity | ||||
| Retained earnings | $1734 | $1676 | $1632 | $1582 |
| Other shareholder equity | -$360 | -$382 | -$317 | -$305 |
| Total shareholder equity | $1346 | $1367 | $1329 | |
| (in millions $) | 30 Oct 2024 | 31 Jan 2024 | 30 Oct 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238 | $206 | $168 | |
| Short term investments | ||||
| Net receivables | $733 | $695 | $836 | $645 |
| Inventory | $552 | $585 | $664 | $523 |
| Total current assets | $1605 | $1626 | $1820 | $1425 |
| Long term investments | $20 | $20 | $40 | |
| Property, plant & equipment | $1534 | $1412 | $1270 | $1376 |
| Goodwill & intangible assets | $194 | $192 | $240 | |
| Total noncurrent assets | $1978 | $1705 | $1881 | |
| Total investments | $20 | $20 | $40 | |
| Total assets | $3736 | $3604 | $3525 | $3306 |
| Current liabilities | ||||
| Accounts payable | $588 | $600 | $707 | $667 |
| Deferred revenue | ||||
| Short long term debt | $182 | $354 | $445 | |
| Total current liabilities | $772 | $822 | $1105 | $1147 |
| Long term debt | $1087 | $1094 | $1089 | $717 |
| Total noncurrent liabilities | $1375 | $1388 | $1069 | |
| Total debt | $1276 | $1443 | $1162 | |
| Total liabilities | $2311 | $2197 | $2627 | $2216 |
| Shareholders' equity | ||||
| Retained earnings | $1734 | $1574 | $1284 | $1159 |
| Other shareholder equity | -$360 | -$362 | -$439 | -$289 |
| Total shareholder equity | $1264 | $898 | $947 | |
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1016 | $1019 | ||
| Cost of revenue | $760 | $773 | ||
| Gross Profit | $256 | $246 | ||
| Operating activities | ||||
| Research & development | $16 | $15 | ||
| Selling, general & administrative | $68 | $75 | ||
| Total operating expenses | $84 | $90 | ||
| Operating income | $172 | $156 | ||
| Income from continuing operations | ||||
| EBIT | $168 | $152 | ||
| Income tax expense | $40 | $47 | ||
| Interest expense | $19 | $21 | ||
| Net income | ||||
| Net income | $109 | $84 | ||
| Income (for common shares) | $109 | $84 | ||
| (in millions $) | 30 Oct 2024 | 31 Jan 2024 | 30 Oct 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3994 | $4321 | ||
| Cost of revenue | ||||
| Gross Profit | $960 | $885 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $346 | $313 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $111 | $102 | ||
| Interest expense | -$49 | -$45 | ||
| Net income | ||||
| Net income | $374 | $209 | ||
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $109 | $84 | $50 | |
| Operating activities | ||||
| Depreciation | $36 | $37 | $41 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6 | $7 | $6 | |
| Total cash flows from operations | $207 | $176 | $105 | |
| Investing activities | ||||
| Capital expenditures | -$52 | -$43 | -$54 | |
| Investments | ||||
| Total cash flows from investing | -$235 | -$51 | -$41 | -$54 |
| Financing activities | ||||
| Dividends paid | -$93 | -$24 | -$23 | -$22 |
| Sale and purchase of stock | -$47 | -$18 | -$26 | |
| Net borrowings | -$45 | -$125 | $31 | |
| Total cash flows from financing | -$415 | -$131 | -$166 | -$29 |
| Effect of exchange rate | -$57 | -$34 | -$7 | -$16 |
| Change in cash and equivalents | -$15 | -$9 | -$38 | $6 |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $445 | $250 | ||
| Operating activities | ||||
| Depreciation | $144 | $160 | ||
| Business acquisitions & disposals | $6 | |||
| Stock-based compensation | $20 | $21 | ||
| Total cash flows from operations | $595 | $257 | ||
| Investing activities | ||||
| Capital expenditures | -$237 | -$195 | ||
| Investments | ||||
| Total cash flows from investing | -$235 | -$214 | -$118 | -$186 |
| Financing activities | ||||
| Dividends paid | -$93 | -$88 | -$84 | -$80 |
| Sale and purchase of stock | -$94 | $3 | ||
| Net borrowings | -$179 | $36 | ||
| Total cash flows from financing | -$415 | -$403 | $145 | -$60 |
| Effect of exchange rate | -$57 | $54 | -$91 | $8 |
| Change in cash and equivalents | -$15 | $32 | $36 | $19 |
News
Fundamentals
| Market cap | $3.59B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 54.30M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.08 |
| Quick ratio | 1.36 |